Vertex CEO on Innovation: The Challenge is Avoiding Complacency

CEO box 2

CEOs on INNOVATION
This interview is an online-only bonus interview, part our CEOs on Innovation report that appeared in the Fall 2017 issue of Innovation Leader magazine.
Jeffrey Leiden is CEO of Vertex Pharmaceuticals, a $1.7 billion maker of drugs for cystic fibrosis. We spoke with him at Vertex’s Boston headquarters about how he oversees the company’s R&D organization.

Early in our conversation with Leiden, he recounted some of the challenges he faced when he was named CEO of the company in late 2011. At the time, the company’s blockbuster drug for hepatitis C, Incivek, was facing stiff competition from a competitor, Gilead, that brought a better treatment to market.

• • •

... continued ...

Gated Article Promo

Read the rest of the article ... and give IL a test drive!

Complete the form below for a 14-day trial of Innovation Leader, including access to case studies, research excerpts, live calls, and other resources. Got questions? Get in touch »
SEE INNOVATION LEADER IN ACTION!
Watch this quick video to see the main benefits of Innovation Leader membership.
 
Innovation Leader
What Is Innovation Leader?
Are you responsible for creating new growth in a large organization? We've got you covered. IL members get full access to our research, articles, case studies, live events, webcasts & conference calls, downloadable resources and more. Become a member »

Case Studies, Articles
Members-only online access to articles, case studies, best practices, video tutorials, more.
RESEARCH REPORTS
Exclusive reports on topics including metrics, benchmarking, labs, compensation, and more.
IL Events LIVE EVENTS
Member discounts to our one-of-a-kind, loved-by-participants live learning events.
Il Resources RESOURCE CENTER
Dozens of downloadable checklists, innovation frameworks, spreadsheets, and dashboards.
Learn More & Become a Member